Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well if this is doomsday then they really fu@ked up BOD member Ken Widder's day. He just bought 450,000 shares at 2.90 and now two weeks later this?
I don't really understand what it all says... but if something like this was going to happen I'm pretty sure Ken would have been in the loop and would have waited...
Instead of speculating, why don't you contact the company and ask/ bring up your concerns?
Nice AH action!
Since 100 of the 205 trial patients wouldn't have ever been enrolled under the new guidelines, I wonder if the fda could request a new trial? I know at the last meeting they said no new safety or efficacy studies ae required but hopefully they mean it!
Am I missing something... I scanned through the results... why the huge drop on positive phase 3?
Usually a high volume day like today would have seen a bigger gain.... but given the market today we faired quite well.
Happy holidays y'all!
Some chunks being bought up at 1.30 pre market
This history of evk-001 is quite interesting if you've never looked into it.goes back as far as 1994 as far as I can tell. And all I've learned makes me extremely bullish!
About time! Nice to see ihub back up and running too!
Another patent
OK someone on here saw my comment and figured they would stick it to me buying low afterhours just to bring it down.
Holy s#it it's a Christmas miracle! Closed other than red on a news day!
Nice another patent for the portfolio!
That date passed by 3 weeks ago
Well let's hope for approval and quick commercialization...
I read a bit more into it and see that their product basically did work just fine and they had positive results at 28 of the different test facilities.... it was about a dozen or so where there were issues.... so it could be just inconsistancy in administration of the drug that skewed the test results...
And you are right, the main ingredient has been in use for 35 plus years and is already approved so it's just their nasal formula...
Looks like dead money...?
Don't know if fda would approve a drug that failed it's phase 3 trials....
It all seems confusing.... the drug failed phase 3, then they had a brand name approve for it by the fda... why are they even going through any of this?
Well the conference has come and gone, seems like no new info out of it... and no new buyers knocking down the door pre market
Like what I read here from the latest earnings call...
http://charts.stocktwits.com/production/original_68427290.?1480780854
Cold jump from a p2 to p3 trial in a flash
I'm down pretty big on this stock and in retrospect I could have sold when it hit 2.90 on that last run before the offering... I would have almost been out even.... but I also did not expect it to be at 1.35 a week later... hindsight is 20/20.... I don't know if Mondays Co french is going to do anything for the stock price. Not sure if they will have any new data they didn't have yesterday... all it takes is for the right people to be in the crowd and a partnership or buyout could happen....
Congrats to all you longs here for the big jump today, but I feel like nvcn could have worked a better deal. This cash won't even cover the 91m fine, and they will lose their facility... hope this works out though!
What do you mean by "changes everything"? Do you mean changes the direction of the company? Or a change in the way the market perceives the positive news?
The trend here for the most part, at least 90% of the time over the last few month's, is when good news come out, the stock spikes in pre market and then goes down over the session, so really to think that Monday should be any different is just a dream it feel's like!
It would be fair to assume the news will be favorable... just raised cash for 2017 to fund phase 2, they just signed a production agreement.... why do that if the drug is failing in trials? My guess is they already have a strong idea of the results for cohort 3 and that the results are positive.
I can't explain the price action on this stock.... it blows my mind. Heavily manipulated, maybe someone is accumulating a ton of shares down here and it's being held down for that...? Maybe someone knows something we don't and is dumping their shares... hard to say...
The market was expecting progression free survival of 128 days.... they feel let down. Lol
This mornings news is excellent! 127 days of progression free survival is a new lifeline for these people! Drug is working as good or better than other RECENTLY APPROVED meds, with similar or side effects no worse!
The science is working, and in time, with patience, can ultimately save lives!
News out!
Steady climb last couple of sessions with a big boost in volume yesterday. Another big volume day tomorrow and this could really run. Huge short interest here too, good news from the company and this make a monster run
I think the bottom line is that the company isn't really concerneed with current shareholders. They are concerned with funding their operations and seeing their science through to fruition.
If you believe in the end game here, then this dilution will be the difference between a 20 dollar stock and a 17 dollar stock and either of those outcome's are far better than where we sit today. Fact is, without days like today they will not be able to fund the program, and without that, this is all nothing.
A partnership with someone else would have been more favorable but let's not forget we aren't even out of phase 1 yet. It's possible that even if there are really any interested parties, they may want to wait and see how phase 2 progresses first before teaming up.
Well obviously these companies with no revenue need money to operate so this is no surprise here to anyone. I wish they could have funded their operation's in a different way maybe by means of partnership but they didn't. A possible partnership is still on the table and the only good news here is they should now be fully funded through 2017 especially with the 2 mil NCI grant with the additional 3 million that is possible. We should hear some positive results on December 5th and then phase 1 is behind us. Phase 2 through 2017 and by end of 2017 we could be seeing 7-10 a share. At least we know there will be no more dilution for a long while and at the end of the day we still have and low float.
Was thinking the same!
Looks like we're heading back to last week's pricing.... people selling based on OLD news, not thinking ahead to December 5th, or maybe sooner. Lots of updates to come, this is just another chance to add!
Little bit of after hours action on this thing for the first time in a long while. Nice to see.
On or around December 5th I would say!
This isn't new though.... this is just an amendment to the offering that was posted back on OctOber 28th. It only dropped 10 cents from where it was on Oct. 28th within the next few trading days... so I think that the two sells ah at 2.20 were just people who obviously don't follow this stock at all and thought it was a new offering.
Anyone know why they keep posting these amended s1's? I can't seem to find what it is that is being amended.... but Cleary it freaked a couple people out tonight...maybe they are new and never saw the original s1, or maybe there is something in the amendment that is not great
.... I'm not sure
Lol the 8k isn't news it's just paperwork.
Nothing but positive news short term here. I'm anticipating positive final phase 1 results, which is why management has already put a contract in place for phase 2.
2.70 bid
They broke the pattern of 830 news releases today... put out news during regular trading hours and it seemed to work better. Didn't close at HOD but till held its gains quite well. See what tomorrow brings. Hoping for another big volume day and a test of 3.
Still waiting for update on university head and neck cancer study. And phase 1 results expected in the next month. Lots of catalysts here.